[{"Assets_0_Q3_USD":"10677500000.0","CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q3_USD":"0.26","CommonStockSharesIssued_0_Q3_shares":"134600000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.37","EarningsPerShareBasic_3_Q3_USD":"-0.87","EarningsPerShareDiluted_1_Q3_USD":"-0.37","EarningsPerShareDiluted_3_Q3_USD":"-0.87","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"121400000.0","NetIncomeLoss_1_Q3_USD":"-49400000.0","NetIncomeLoss_3_Q3_USD":"-116900000.0","OfficialName":"Perrigo Company plc Ordinary Shares","PaymentsOfDividends_3_Q3_USD":"107000000.0","RevenuesConverted_1_Q3_USD":"1100200000.0","RevenuesConverted_3_Q3_USD":"3296300000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"4602700000.0","Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"134600000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"134400000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"134600000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"134400000.0","filed":"20221108","footnote":null,"form":"10-Q","fp":"Q3","fy":"2022.0","name":"PERRIGO CO PLC","period":"20220930","qtrs":"0","uom":"USD"}]